Search

1. Observational real-world evidence update: prophylaxis of hereditary angioedema with Takhzyro and C1 inhibitors : effectiveness and value

Author(s):

Bloudek, Lisa, author
Jaksa, Ashley, author
McKenna, Avery, author
Carlson, Josh, author
Chen, Yilin, author
Patrick, Amanda, author
Campbell, Jon D., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 24, 2021

Subject(s):

Angioedemas, Hereditary -- prevention & control
Complement C1 Inhibitor Protein
United States

2. Betibeglogene autotemcel for beta thalassemia: effectiveness and value : final evidence report

Author(s):

Beaudoin, Francesca L., author
Richardson, Marina, author
Synnott, Patricia G., author
Lancaster, Victoria, author
Fluetsch, Noemi, author
Herce-Hagiwara, Belén, author
Campbell, Jon D., author
Pearson, Steven D., author
Rind, David M., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, July 19, 2022

Subject(s):

beta-Thalassemia -- therapy
Biological Products -- therapeutic use
Genetic Therapy
United States

3. Tirzepatide for type 2 diabetes: final report

Author(s):

Lin, Grace A., author
Nikitin, Dmitriy, author
Moradi, Ashton, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Campbell, Jon D., author
Brouwer, Elizabeth, author
Chen, Yilin, MPH, author
Hansen, Ryan N., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 15, 2022

Subject(s):

Diabetes Mellitus, Type 2 -- drug therapy
Gastric Inhibitory Polypeptide -- therapeutic use
Hypoglycemic Agents -- therapeutic use
Incretins -- therapeutic use
United States